Analysts offer 7 reasons why a Covid-19 vaccine could fail

In a new report, SVB Leerink analysts analyzed where the market may be overeager and what issues could trip up the top vaccine candidates. “We’re entering into a period that will be less about exciting promise and more about dirty, disciplined, agonizingly boring commercial execution," one analyst said.